Kriya Therapeutics, Inc.

Join us at CGTP Summit 2024 where our Chief Gene Therapy Officer, J Fraser Wright, Ph.D., will share insights on development and manufacturing strategies that impact commercialization during a Q&A session. Click here for more details: https://bit.ly/3CvsNsn. ? #GeneTherapy #BioTech #CGTPSummit2024

Proud to announce new preclinical data in Molecular Therapy demonstrating the potential of our investigational AAV-FGF21 gene therapy (KRIYA-497) for #MASH. Research from Universitat Autonoma de Barcelona (UAB) showed durable reversal of hepatic fibrosis from intramuscular gene therapy, halting liver tumor development in animal models in long-term follow-up. Congratulations to Dr. Fátima Bosch and the UAB team! Read more https://bit.ly/48My7mY ? #GeneTherapy #BiotechNews #LiverDisease #Research?

Exciting news! We’re proud to announce that we’ve been named one of BioSpace’s 2025 Best Places to Work! This recognition highlights our commitment to fostering a workplace that values collaboration, supports learning, and drives innovation. A huge thank you to everyone at Kriya who makes our company such a special place to work. We appreciate the recognition of our dedication to building a great company and culture. Here’s to continued growth! https://bit.ly/4eajevY ? #biopharma #lifesciences #biospace

This #DiabetesAwarenessMonth, we reaffirm our commitment to transforming the treatment of type 1 diabetes and celebrate our dedicated team and fellow researchers who are at the forefront of pioneering innovative solutions for more effective management of this disease. For the 5 million people in the US and EU living with type 1 diabetes, investing in research is key to improving quality of life and delivering better control of their disease. Discover more about our investigational candidate, Kriya-839, a potential one-time gene therapy for type 1 diabetes: https://bit.ly/4huwzSv #GeneTherapy #Type1Diabetes?

Today’s the day! Join us at @Alliance for Regenerative Medicine’s 2024 Cell & Gene Meeting on the Mesa to hear our President and Chief Operating Officer, Curt Herberts present on Kriya on Wednesday, October 9th in FLW Ballroom G at 11:30am MST. #genetherapy

Looking forward to attending the H.C. Wainwright & Co., LLC MASH investor conference today. Hope to see you there!?

We are excited for this year’s @Alliance for Regenerative Medicine’s 2024 Cell & Gene Meeting on the Mesa, where our President & Chief Operating Officer, Curt Herberts, will be sharing company highlights during a presentation on October 9th at 11:30am MST.

Join us tomorrow for a fireside chat at RBC Capital Markets Biotechnology Private Company Conference where we’ll share on how we aim to make #genetherapy more accessible to the patients that need it.

We hope to see you at the Bank of America Healthcare Trailblazers Private Company Conference where we will be sharing company updates.?

Join our Chief Gene Therapy Officer, J Fraser Wright, Ph.D., at the 10th Annual World Medical Innovation Forum for a panel discussion about viral vector manufacturing and the delivery of #geneticmedicines. Learn more here: https://bit.ly/3XA5sha